Schepens Eye Research Institute - Click to return to home page

2007 Faculty Publications

  1. Abelson MB, Sullivan DA, Ousler GWIII, Smith L, Maffei C. What you missed at the TFOS Meeting: A thorough update on the latest research in corneal and external disease. Rev Ophthalmol 2007;14(12):56-61.

  2. Apfelbaum H, Pelah A, Peli E. (2007) Heading assessment by "tunnel vision" patients and control subjects standing or walking in a virtual reality environment. ACM Transactions on Applied Perception. 4(1): Article 8

  3. Argueso P, Cao Z, Mantelli F, Tisdale A, Barabino S, Dana R, Gipson I, Panjwani N. MUC16 is a cell surface ligand for galectin-3 on human corneal epithelial cells, Submitted.

  4. Bachmann B, Bock F, Wiegand S, Maruyama K, Dana R, Kruse F, Luetjen-Drecoll E, Cursiefen C. VEGF-A neutralization after high-risk corneal transplantation promotes graft survival. Arch Ophthalmol 2007; in press.

  5. Barabino S, Rolando M, Chen L, Dana MR. Exposure to a dry environment induces strain-specific responses in mice. Exp Eye Res 2007; 84:973-977.

  6. Barcia RN, Dana MR, Kazlauskas A. Corneal Graft Rejection Is Accompanied by

  7. Apoptosis of the Endothelium and Is Prevented by Gene Therapy With Bcl-xL. Am J Transplant. 2007; 7:2082-9.

  8. Bex, P.J. and K. Langley, The perception of suprathreshold contrast and fast adaptive filtering. Journal of Vision, 2007. 7(12): p. 1-23.

  9. Bex, P.J., I. Mareschal, and S.C. Dakin, Contrast gain control in natural scenes. Journal of Vision, 2007. 7(11): p. 12:1-12.

  10. Blalock TD, Spurr-Michaud SJ, Tisdale AS, Heimer SR, Gilmore MS, Ramesh V, Gipson IK.  Functions of MUC16 in corneal epithelial cells.  Invest Ophthalmol Vis Sci.  2007;48:4509-4518.

  11. Bryan BA, Walshe TE, Mitchell DC, Havumaki JS, Saint-Geniez M, Maharaj AS, Maldonado AE, D'Amore PA. Coordinated vascular endothelial growth factor expression and signaling during skeletal myogenic differentiation. Mol Biol Cell, 2007 (in press).

  12. Caspi R, Forrester J, Stein-Streilein, J.  The role of NK inhibitory receptors in the generation of peripheral tolerance through the eye. ARVO Annual Meeting, Fort Lauderdale, FL.  May 6–May 10, 2007.

  13. Chen L, Hamrah P, Cursiefen C, Zhang Q, Pytowski B, Streilein JW, Dana MR. VEGFR-3 mediates induction of corneal alloimmunity. Ocul Immunol Inflamm 2007; 15:275-8.

  14. Chen L, Hodges RR, Funaki Cm Zoukhri Zm Gauvub R, Perez DM, Dartt DA. The effects if a1-adrenergic receptors on shedding of biologically active EGF in freshly isolated lacrimal gland epithelial cells. Am J Physiol Cell Physiol 2006, 291:C946-956. (Subject of Editorial Focus article by Snider AC and Meier KE, . Am J Physiol Cell Physiol 2007, 292:C1-C3.)

  15. Chen L, Huq S, Gardner H, de Fougerolles AR, Barabino S, Dana MR. Very Late Antigen (VLA)-1 Blockade Markedly Promotes Survival of Corneal Allografts. Arch Ophthalmol 2007;125: 783-788.

  16. Chong E-M, Dana MR. Acanthamoeba keratitis. Int Ophthalmol Cl 2007; 47:33-46.

  17. Chong E-M, Dana MR. Immunologic mechanisms of corneal transplant rejection. Int Ophthalmology [Special Corneal Transplantation Issue] 2007. PMID 17673946.

  18. Collins JF, Dartt DA, Dana R. Mist delivery of eye medication to the anterior segment. Am J Ophthalmol 2007; 144:137-9.

  19. Crossland, M.D., S.C. Dakin, and P.J. Bex, Illusory stimuli can be used to identify retinal blind spots. PLoS ONE, 2007. 2(10): p. e1060.

  20. Dagher MH, Dana MR, Jurkunas U. Keratoglobus in association with posterior polymorphous dystrophy. Cornea 2007; in press.

  21. Dana R. Comparison of topical interleukin-1 versus tumor necrosis factor-alpha blockade with corticosteroid therapy on murine corneal inflammation, neovascularization, and transplant survival (AOS Thesis). Trans Am Ophthalmol Soc 2007; in press.

  22. Delori, FC, Webb, RH, and Sliney,D ìMaximum Permissible Exposures for Ocular Safety (ANSI 2000) with Emphasis on Ophthalmic Devicesî, JOSA A 24 1250-1265 (2007)

  23. Diebold Y, Chen LL, Tepavcdvic V, Ferdman D, Hodges RR, Dartt DA. Lymphocytic infiltration and goblet cell marker alteration in the conjunctiva of the MRL/MpJ-Fas(lpr) mouse model of Sjogren's syndrome. Exp Eye Res 2007, 84:500-512.

  24. Falkenberg, H.K. and P.J. Bex, Sources of motion-sensitivity loss in glaucoma. Invest Ophthalmol Vis Sci, 2007. 48(6): p. 2913-21.

  25. Falkenberg, H.K. and P.J. Bex, Contextual modulation of the motion aftereffect. J Exp Psychol Hum Percept Perform, 2007. 33(2): p. 257-70.

  26. Fabiani C, Barabino S, Rashid S, Dana MR. Corneal Epithelial Proliferation and Thickness in a Mouse Model of Dry Eye. Exp Eye Res, Submitted.

  27. Falkenberg, H.K., G.S. Rubin, and P.J. Bex, Acuity, crowding, reading and fixation stability. Vision Res, 2007. 47(1): p. 126-35.

  28. Fernando NT, Koch M, Rothrock C, Gollogly LK, D'Amore PA, Ryeom SW, Yoon, SS. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by upregulation of multiple pro-angiogenic factors. Clinical Cancer Research, 2007 (in press).

  29. Fullerton M, Peli E. (2007) People with visual impairment prefer TV viewing using a contrast enhancement consumer product. SID 07 Digest 15.4: 975-978

  30. Fullerton M, Woods RL, Vera-Díaz FA, Peli E. (2007) Measuring perceived video quality of MPEG enhancement by people with impaired vision. J Opt Soc Am (A) 24(12): B174-B187.

  31. Funaki C, Hodges RR, Dartt DA. Role of cAMP inhibition of p44/p42 mitogen activated protein kinase in potentiation of protein secretion. Am J Physiol Cell Physiol 2007. In Press.

  32. Gerhardinger C, Dagher Z, Sebastiani P, Park YS, Lorenzi M: Overexpression of genes of the TGF-beta pathway in retinal capillaries is the common target of drugs that prevent diabetic retinopathy. Diabetes 56 (Supplement 1): A212, 2007.

  33. Gipson et al. Research in dry eye: Report of the Research Subcommittee of the International Dry Eye Workshop. Ocular Surface 2007; 5:179-194.

  34. Gipson IK.  2007 Friedenwald Award Lecture.  The Ocular Surface:  The challenge to enable and protect vision.  Invest Ophthalmol Vis Sci.  2007;48:4390-4398.

  35. Gipson IK, Argüeso P, Beuerman R, Bonini S, Butovich I, Dana R, Dartt D, Gamache D, Ham B, Jumblatt M, Korb D, Kruse F, Ogawa Y, Paulsen F, Stern M, Sweeney DF, Tiffany J, Ubels J, Willcox M. “Research in dry eye: Report of the research subcommittee of the international dry eye workShop (2007).” Ocul Surf. 2007;5(2):179-194.

  36. Gipson IK, Blalock T, Tisdale A, Spurr-Michaud S, Allcorn S, Stavreus-Evers A, Gemzell K.  MUC16 is lost from the uterodome (pinopode) surface of the receptive human endometrium:  In vitro evidence that MUC16 is a barrier to trophoblast adherence.  Biol Reprod. DOI:10.1095/biolreprod.106.058347

  37. Goldstein RB, Dugan E, Trachtenberg F, Peli E. (2007) The impact of a video intervention on the use of low vision assistive devices. Optometry and Vision Science. 84(3): 208-217

  38. Goldstein RB, Woods RL, Peli E. (2007) Where people look when watching movies: Do all viewers look at the same place? Computers in Biology and Medicine. 37(7): 957-964. electronic publication 28 September 2006; DOI: 10.1016/j.compbiomed.2006.08.018.

  39. Goodwin AM, Kitajewski J, D'Amore PA. Wnt1 and Wnt5a affect endothelial proliferation and capillary length; Wnt2 does not. Growth Factors, 2007, 25: 25-32.

  40. Hamrah P, Dana MR. Cornea antigen-presenting cells. In: Niederkorn JY, Kaplan H. Immune Response and the Eye. Chemical Immunol Allergy 2007; 92: 58-70.

  41. Hamrah P, Haskova Z, Taylor AW, Zhang Q, Ksander BR, Dana MR. Local treatment with alpha-melanocyte stimulating hormone reduces corneal allorejection. Submitted.

  42. Hamrah P, Yamagami S, Liu Y, Zhang Q, Vora SS, Lu B, Gerard CJ, Dana MR. Deletion of the chemokine receptor CCR1 prolongssuppresses corneal allorgrraft survival. Invest Ophthalmol Vis Sci. 2007; 48:1228-1236.

  43. Harper, J., Yan, L., Loureiro, R.M., Ng, Y.-S., Inmin, W., Fang, J., D'Amore, P.A., and Moses, M.A. (2007) Repression of VEGF expression by the zinc finger transcription factor ZNF24. Cancer Research, 2007, 67:8736-8741.

  44. Hodges RR, Horikawa Y, Rios JD, Shatos MA, Dartt DA. Effect of protein kinase C and Ca2+ on p42/p44 MAPK, Pyk2, and Src activation in rat conjunctival goblet cells. Exp Eye Res 2007, In Press.

  45. Im E, Kazlauskas A. PtdIns-4,5-P2 as a potential therapeutic target for pathologic angiogenesis. Expert Opin Ther Targets. 2007;11:443- 51.

  46. Im E, Kazlauskas A. SFKs promote vessel stability by antagonizing the Rho/ROCK pathway. J Biol Chem. 2007 Aug 7; 101:357-367.

  47. Jin Y, Shen L, Chong EM, Hamrah P, Zhang Q, Chen L, Dana MR. The chemokine receptor CCR7 mediates corneal antigen-presenting cell trafficking. Mol Vision 2007; 13: 626-634.

  48. Langley, K. and P.J. Bex, Contrast Adaptation Implies Two Spatio-Temporal Channels but Three Adapting Processes. Journal of Experimental Psychology: Human Perception and Performance, 2007. 33(6): p. xx-xx (in press).

  49. Lao CH, Watte C, Stein-Streilein J. In vivo Anti-ly49c/I Treatment Prevents the Development of Acaid and Allogeneic Corneal Graft Survival.  ARVO Annual Meeting, Fort Lauderdale, FL.  May 6–May 10, 2007.

  50. Lei H, Hovland P, Velez G, Haran A, Gilbertson D, Hirose T, Kazlauskas A.

  51. A potential role for PDGF-C in experimental and clinical proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci. 2007; 48:2335-42.

  52. Lei H, Venkatakrishnan A, Yu S, Kazlauskas A. Protein Kinase A-dependent Translocation of Hsp90alpha_Impairs Endothelial Nitric-oxide Synthase Activity in High Glucose and Diabetes. J Biol Chem. 2007 Mar 30;282(13):9364-71.

  53. Lichtenstein L, Barabas J, Woods RL, Peli E. (2007) A feedback-controlled interface for treadmill locomotion in virtual environments.  ACM Transactions on Applied Perception. 4(1): article 7.  DOI: 10.1145/1227134.1227141.

  54. Lin, CP and Webb, RH  Fiber-coupled multiplexed confocal microscope US Patent 7,292390 (2007).

  55. Lorenzi M, Feke GT, Cagliero E, Pitler L, Schaumberg DA, Berisha F, Nathan DM, McMeel JW: Retinal haemodynamics in individuals with well-controlled type 1 diabetes.  Diabetologia 2007 In press. DOI 10.1007/s00125-007-0872-0.

  56. Lorenzi, M. The polyol pathway as a mechanism for diabetic retinopathy: Attractive, elusive,  and resilient. Experimental Diabetes Research 2007; vol 2007, Article ID 61038, doi:10.1155/2007/61038.

  57. Luo G, Lichtenstein L, Peli E. (2007) Collision judgement when viewing minified images through a HMD visual field expander. SPIE conference BiOS, San Jose, CA 2007. In press

  58. Mandel AJ, Bowers AR, Goldstein RB, Peli E. (2007) Analysis of driving behavior where it matters. In: Proceedings of the Driving Simulator Conference (DSC) North America 2007: 181-190

  59. Maruyama K, Asai J, Masaaki Ii, Thorne T, Losordo DW, and D'Amore PA. Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. Am J Path, 2007, 170:1178-1191.

  60. Maruyama K, Jackson DG, Kinoshita S, D’Amore PA, Stein-Streilein J.  Differences in Corneal Lymphangiogenesis Between BALB/c and C57BL/6 Mice. ARVO Annual Meeting, Fort Lauderdale, FL.  May 6–May 10, 2007.

  61. Miljanovi B, Dana MR, Sullivan DA, Schaumberg DA. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol 2007; 143:409-415.

  62. Miyamoto K, Yamagami S, Barcia R, Gregory M, Dana MR, Ksander BR.  Reverse signaling through Fas ligand on corneal endothelial cells triggers the release of MIP-2. J Immunol 2007, Submitted.

  63. Murphy PJ, Lau JSC, Sim MML, Woods RL. (2007) How red is a white eye? Clinical grading of normal conjunctival hyperaemia. Eye. 21(5): 633-638. electronic publication 3 March, 2006; DOI:10.1038/sj.eye.6702295.

  64. Nakao S, Hata Y, Miura M, Kimura YN, Kawahara S, Kita T, Jin Y, Dana R, Kuwano M, Ono M, Ishibashi T, Hafezi-Moghadam A. Dexamethasone inhibits IL-1 beta-induced corneal neovascularization: Role of NF-kB-activated stromal cells in inflammatory angiogenesis. Am J Pathol 2007; 171:1058-65.

  65. Nakazawa T, Takeda M, Lewis GP, Cho K-S, Jiao J, Wilhelmsson U, Fisher SK, Pekny M, Chen DF*, and Miller JW*. Attenuated Glial Reactions and Photoreceptor Degeneration after Retinal Detachment in Mice Deficient in Glial Fibrillary Acidic Protein and Vimentin. (2007) Invest. Ophthalmol. Vis. Sci. 48, 2760-2768 (*co-corresponding authors).

  66. Ng TF, Kitaichi N and Taylor AW. In Vitro Generated Autoimmune Regulatory T Cells Enhance Intravitreous Allogeneic Retinal Graft Survival. Invest Ophthalmol Vis Sci. 2007; 48:5112-5117.

  67. Ng TF, Lavik E, Keino H, Taylor AW, Langer RS, Young MJ. Creating an immune-privileged site using retinal progenitor cells and biodegradable polymers. Stem Cells. 2007; 25:1552-1559. (PMID 17548532)

  68. Nowak M, Stein-Streilein J. Invariant NKT Cells and Tolerance [review]. Int Rev Immunol. 2007;26:95-119.

  69. Peli E. (2007) Vision multiplexing: An optical engineering concept for low-vision aids. SPIE Conference on Current Developments in Lens Design and Optical Engineering VIII. In press

  70. Peli E. (2007) Image enhancement for impaired vision: The challenge of evaluation. International IEEE-BAIS Symposium on Research on Assistive Technologies (RAT-07) 1: 47-58

  71. Peli E, Luo G, Bowers A, Rensing N. (2007) Applications of augmented-vision head-mounted systems in vision rehabilitation. J. SID 15(12): 1037-1045

  72. Peli E, Luo G, Bowers A, Rensing N. (2007) Development and evaluation of vision multiplexing devices. International IEEE-BAIS Symposium on Research on Assistive Technologies (RAT-07) 1: 13-20

  73. Peli E, Luo G, Bowers A, Rensing N. (2007) Augmented vision head-mounted systems for vision impairments. The SID Int Symposium, Soc Information Display, Long Beach, CA 2007. SID 07 Digest 1074-1077

  74. Ramsauer M, D'Amore PA. Contextual role for angiopoietins and TGFß1 in blood vessel stabilization. J Cell Sci, 2007, 120:1810-1817.

  75. Rashid S, Dana R. Cicatrizing and autoimmune disorders. In: Niederkorn JY, Kaplan H. Immune Response and the Eye. Chemical Immunol Allergy 2007; 92:195-202.

  76. Rashid S, Jin Y, Ecoiffier T, Barabino S, Schaumberg DA, Dana MR. Topical omega-3 and omega-6 fatty acids for treatment of dry eye. Arch Ophthalmol 2007; in press.

  77. Richards SM, Sullivan DA. Influence of autoimmune disease on the mRNA sequences of androgen and estrogen receptors in the lacrimal gland. Submitted to Arthr & Rheum, December, 2007.

  78. Rios JD, Ghinelli E, Gu J, Hodges RR, Dartt DA. Role of neutrophins and neurotrophin receptors in rat conjunctival goblet cell secretion and proliferation. Invest Ophthalmol Vis Sci. 2007, 48:1543-1551.

  79. Romeo GR, Moulton KS, Kazlauskas A. Attenuated Expression of Profilin-1 Confers Protection From Atherosclerosis in the LDL Receptor-Null Mouse.

  80. Circ Res. 2007; 101:357-67.

  81. Schaumberg DA, Dana R, Buring JE, Sullivan DA. Prevalence and risk factors for dry eye disease among US men. Submitted to JAMA, December, 2007.

  82. Schaumberg DA, Gulati G, Mathers WD, Clinch T, Lemp M, Nelson JD, Foulks GN, Dana R. Development and Validation of a Global Dry Eye Symptom Index. [Innovative Techniques and Technology] Ocular Surface 2007; 5:50-57.

  83. Schirra F, Richards SM, Sullivan DA. Androgen influence on cholesterogenic enzyme mRNA levels in the mouse meibomian gland. Curr Eye Res 2007;32:393-398.

  84. Shen L, Barabino A, Taylor AW, and Dana MR. The effect of the ocular microenvironment in regulating corneal dendritic cell maturation. Arch. Ophthalmol. 2007; 125:908-915.

  85. Shen L, Jin Y, Freeman GJ, Sharpe AH, Dana MR. The function of donor versus recipient PD-L1 in corneal allograft survival. J Immunology 2007; 179: 3672-9.

  86. Singh PK, Wen Y, Swanson BJ, Shanmugam K, Kazlauskas A, Cerny RL,

  87. Gendler SJ, Hollingsworth MA. Platelet-derived growth factor receptor beta-

  88. mediated phosphorylation of MUC1 enhances invasiveness in pancreatic adenocarcinoma cells. Cancer Res. 2007; 67:5201-10.

  89. Sonoda KH, Nakamura T, Young HA, Hart D, Carmeliets P, Stein-Streilein, J.  NKT cell-derived urokinase-type plasminogen activator promoted peripheral tolerance associated with eye.  J Immunol 2007;179:2215-2222.

  90. Spurr-Michaud S, Argüeso P, Gipson IK. “Assay of mucins in human tear fluid.” Exp Eye Res. 2007;84(5):939-950.

  91. Stein-Streilein, J.  Antigen Presenting Cell Interactions with Cells During Anterior Chamber Associated Immune Deviation. In: Zierhut, M, Rammense, H-G, Streilein, JW, editors. Antigen-presenting Cells and the Eye.  New York: Egerton Group Ltd.; 2007 p. 17-25.

  92. Stein-Streilein, J.  Immune privilege and Regulatory cells.  ImmuoRio, Rio De Janeiro, Brazil.  August 21–25, 2007.

  93. Stein-Streilein, J. Regulatory T cells and ACAID.  International Ocular Inflammation Society 9th Annual Congress.  Paris, France.  September 17–20, 2007.

  94. Stein-Streilein, J.  Immune privilege and Regulatory cells. 40th Annual Meeting of the Society for Leukocyte Biology.  Cambridge, MA.  October 11–13, 2007.

  95. Stein-Streilein J, Taylor AW. An Eye's View of T Regulatory Cells. J Leuk Biol 2007; 81:593-598. (PMID: 17194735)

  96. Stein-Streilein J, Watté C. Cross Talk among Cells Promoting Anterior Chamber-Associated Immune Deviation  [review].  In: Niedferkorn JY, Kaplan HJ (eds): Immune Response and the Eye. Chem Immunol Allergy. Basel, Karger, 2007;92:115-30

  97. Sumiyoshi M, Ricciuto J, Tisdale A, Gipson IK, Mantelli F, Argüeso P. “The role of epithelial mucin O-glycans in the prevention of apical cell surface adhesion.” Invest Ophthalmol Vis Sci. (in press)

  98. Suzuki T, Schirra F, Richards SM, Jensen RV, Sullivan DA. Estrogen and progesterone control of gene expression in the mouse meibomian gland. Invest Ophthalmol Vis Sci 2007, in press.

  99. Taylor AW. Ocular immunosuppressive microenvironment. Chem. Immunol Allergy 2007; 92:71 - 85. (PIMD: 17264484)

  100. Zhang-Hoover J,  Stein-Streilein, J.  Therapies based on principles of ocular immune privilege [review].  Chem Immunol Allergy.  2007;92:317-27.

SEO by Artio